血塞通注射液对急性高血压性脑出血患者的治疗分析

目的观察血塞通注射液治疗急性高血压性脑出血的临床效果。方法128例急性高血压性脑出血患者被随机分为治疗组(血塞通注射液)和对照组(常规治疗),治疗组在常规治疗的基础上加用血塞通(发病24h开始应用)治疗。2组经治疗后进行疗效评定,比较治疗前(发病24h)与治疗后(发病28d)2组的脑血肿体积、神经功能缺损评分、显效率和有效率。结果治疗后,治疗组的脑血肿体积减少54.7%,对照组减少39.7%,2组间对血肿的吸收差异有统计学意义(P<0.05);治疗组的神经功能缺损评分值显著低于对照组(P<0.01);治疗组的显效率和有效率均比对照组显著提高(P<0.01)。结论血塞通是治疗急性高血压性脑出血的安全、有效药物。

Effect of Xuesaitong injection on patients with acute hypertensive cerebral hemorrhage

Objective To observe the clinical effect of Xuesaitong injection (XSTI) on patients with acute hypertensive cerebral hemorrhage. Methods 128 cases patients with acute hypertensive cerebral hemorrhage were randomly individed into treatment group (XSTI group) and control group (routine group), they were treated with conventional treatment, and XSTI were given additionally to the treatment group(be ill 24h later), treatment effects of the two groups were assessed. Brain hematoma volume, neuro-function deficit scores ,excellence rates and effective rates of pre-treatment (be ill 24h later )and post-treatment (be ill 28d later)were compared. Results After treatment, brain hematoma volume of treatment group and control group decreased 54.7% and 39.7% respectively, two groups had significant difference (P<0.05).The neuro-function deficit scores of treatment group were lower than control group (P<0.01). Excellence rates and effective rates of treatment group than control group raised significantly (P<0.01). Conclusion XSTI is a safe and effective drug on treatment of acute hypertensive cerebral hemorrhage.